| Acne |
No |
| Active substance |
Paliperidone |
| Also known as |
Paliperidone |
| Aromatization |
No |
| Blood pressure |
Can cause orthostatic hypotension |
| Chemical name |
9-hydroxyrisperidone |
| Classification |
Antipsychotic |
| Dosage (medical) |
Typically starts at 3 mg per day, can be adjusted up to 12 mg per day based on clinical response |
| Dosage (sports) |
Not applicable |
| Effects |
Symptom reduction in schizophrenia and schizoaffective disorder |
| Formula |
C23H27FN4O3 |
| Half-life |
Approximately 23 hours |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Monitoring plasma levels not typically required but may be performed to ensure therapeutic levels |
| Main action |
Antagonist of serotonin type 2 (5HT2) and dopamine type 2 (D2) receptors |
| Side effects |
Extrapyramidal symptoms (EPS), tachycardia, weight gain, dizziness, insomnia, constipation |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Atypical antipsychotic |
| Trade name |
Invega |
| Use in sports |
None |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Janssen-Cilag |
